Sumitra Angepat

Sumitra Angepat is an accomplished leader currently serving as VP, Global Biologics Drug Substance at Bayer, where they oversee a team focused on biological processes, including cell therapies. Previously, they held various roles such as Head of MSAT Upstream at Boehringer Ingelheim and Director of Manufacturing Science and Technology at Orchard Therapeutics. Sumitra's extensive experience encompasses process development, technology transfer, and regulatory compliance within the biotechnology field. They also contributed to CMC Biologics Drug Substance initiatives throughout their career, shaping drug substance strategies from development to post-market stages.